Cargando…
Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in 2019, and the resulting pandemic has already caused the death of over 6 million people. There are currently few antivirals approved for treatment of the 2019 coronavirus disease (COVID-19), and more options would be beneficial,...
Autores principales: | Salgado-Benvindo, Clarisse, Leijs, Anouk A., Thaler, Melissa, Tas, Ali, Arbiser, Jack L., Snijder, Eric J., van Hemert, Martijn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269499/ https://www.ncbi.nlm.nih.gov/pubmed/37212560 http://dx.doi.org/10.1128/spectrum.03273-22 |
Ejemplares similares
-
R-Propranolol Has Broad-Spectrum Anti-Coronavirus Activity and Suppresses Factors Involved in Pathogenic Angiogenesis
por: Thaler, Melissa, et al.
Publicado: (2023) -
Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle
por: Salgado-Benvindo, Clarisse, et al.
Publicado: (2020) -
Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
por: Bonner, Michael Y., et al.
Publicado: (2016) -
Impact of Changes in Human Airway Epithelial Cellular Composition and Differentiation on SARS-CoV-2 Infection Biology
por: Thaler, Melissa, et al.
Publicado: (2023) -
Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection
por: Albulescu, Irina C., et al.
Publicado: (2020)